Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis
about
Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results.Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression
P2860
Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Combination of sofosbuvir, peg ...... matic review and meta-analysis
@ast
Combination of sofosbuvir, peg ...... matic review and meta-analysis
@en
Combination of sofosbuvir, peg ...... atic review and meta-analysis.
@nl
type
label
Combination of sofosbuvir, peg ...... matic review and meta-analysis
@ast
Combination of sofosbuvir, peg ...... matic review and meta-analysis
@en
Combination of sofosbuvir, peg ...... atic review and meta-analysis.
@nl
prefLabel
Combination of sofosbuvir, peg ...... matic review and meta-analysis
@ast
Combination of sofosbuvir, peg ...... matic review and meta-analysis
@en
Combination of sofosbuvir, peg ...... atic review and meta-analysis.
@nl
P2093
P2860
P31
P50
P921
P1433
P1476
Combination of sofosbuvir, peg ...... matic review and meta-analysis
@en
P2093
Bita Behnava
Fardin Dolatimehr
Mohammad Gholami-Fesharaki
P2860
P2888
P356
10.1186/S40199-017-0177-X
P407
P577
2017-04-20T00:00:00Z
P6179
1084984695